Loading clinical trials...
Loading clinical trials...
Phase II Trial of CO2RE Laser for Patients With Stage 0-III Hormone Receptor-Positive Breast Cancer on Aromatase Inhibitors With Vulvovaginal Atrophy
Conditions
Interventions
Carbon Dioxide Fractional Laser
Questionnaire Administration
Start Date
September 10, 2018
Primary Completion Date
September 10, 2021
Completion Date
September 10, 2021
Last Updated
January 6, 2023
NCT06401889
NCT06633926
NCT06324240
NCT06763328
NCT05786664
NCT06153836
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions